دورية أكاديمية

Allograft involvement with posttransplant lymphoproliferative disorders (PTLD) in recipients of liver transplant: a clinicopathological analysis of 17 cases.

التفاصيل البيبلوغرافية
العنوان: Allograft involvement with posttransplant lymphoproliferative disorders (PTLD) in recipients of liver transplant: a clinicopathological analysis of 17 cases.
المؤلفون: Cruz RJ Jr; Starzl Transplantation Institute, UPMC (University of Pittsburgh Medical Center), Pittsburgh, Pennsylvania, USA.; Department of Surgery, UPMC, Pittsburgh, Pennsylvania, USA., Sasatomi E; Department of Pathology, University of North Carolina, Chapel Hill, North Carolina, USA., Hughes CB; Starzl Transplantation Institute, UPMC (University of Pittsburgh Medical Center), Pittsburgh, Pennsylvania, USA.; Department of Surgery, UPMC, Pittsburgh, Pennsylvania, USA., Humar A; Starzl Transplantation Institute, UPMC (University of Pittsburgh Medical Center), Pittsburgh, Pennsylvania, USA.; Department of Surgery, UPMC, Pittsburgh, Pennsylvania, USA., Minervini M; Starzl Transplantation Institute, UPMC (University of Pittsburgh Medical Center), Pittsburgh, Pennsylvania, USA.; Department of Pathology, UPMC, Pittsburgh, Pennsylvania, USA.
المصدر: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society [Liver Transpl] 2024 Aug 01; Vol. 30 (8), pp. 862-865. Date of Electronic Publication: 2024 Apr 12.
نوع المنشور: Letter; Journal Article
اللغة: English
بيانات الدورية: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 100909185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-6473 (Electronic) Linking ISSN: 15276465 NLM ISO Abbreviation: Liver Transpl Subsets: MEDLINE
أسماء مطبوعة: Publication: 2023- : [Philadelphia] : Wolters Kluwer Health, Inc.
Original Publication: Philadelphia, PA : W.B. Saunders Co., c2000-
مواضيع طبية MeSH: Liver Transplantation*/adverse effects , Lymphoproliferative Disorders*/etiology , Allografts*/pathology, Humans ; Male ; Female ; Middle Aged ; Adult ; Postoperative Complications/etiology ; Postoperative Complications/epidemiology ; Postoperative Complications/diagnosis ; Retrospective Studies ; Aged ; Treatment Outcome
References: Lauro A, Arpinati M, Pinna AD. Managing the challenge of PTLD in liver and bowel transplant recipients. Br J Haematol. 2015;169:157–72.
Allen UD, Preiksaitis JK. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33:e13652.
Strouse PJ, Platt JF, Francis IR, Bree RL. Tumorous intrahepatic lymphoproliferative disorder in transplanted livers. AJR Am J Roentgenol. 1996;167:1159–62.
Nuckols JD, Baron PW, Stenzel TT, Olatidoye BA, Tuttle-Newhall JE, Clavien PA, et al. The pathology of liver-localized post-transplant lymphoproliferative disease: A report of three cases and a review of the literature. Am J Surg Pathol. 2000;24:733–41.
Elstrom RL, Andreadis C, Aqui NA, Ahya VN, Bloom RD, Brozena SC, et al. Treatment of PTLD with rituximab or chemotherapy. Am J Transplant. 2006;6:569–76.
تواريخ الأحداث: Date Created: 20240412 Date Completed: 20240717 Latest Revision: 20240717
رمز التحديث: 20240717
DOI: 10.1097/LVT.0000000000000379
PMID: 38607654
قاعدة البيانات: MEDLINE
الوصف
تدمد:1527-6473
DOI:10.1097/LVT.0000000000000379